无并发症恶性疟患者治疗后HRP2清除动力学研究
研究在安哥拉、坦桑尼亚和塞内加尔三个国家的疗效试验中,对537例恶性疟患者的系列样本检测治疗后HRP2浓度,用一阶动力学模型估算半衰期,并评估治疗第3天HRP2浓度与感染复燃的关联。结果显示HRP2呈一阶指数下降,三国半衰期中位数分别为4.5天、4.7天和3.0天,第3天HRP2浓度可预测最终复燃,ROC曲线下面积为0.86(95%CI 0.73-0.99)。
要点
- 537例恶性疟患者治疗后HRP2浓度呈一阶指数下降,三国半衰期中位数分别为4.5天、4.7天和3.0天。
- 治疗第3天HRP2浓度可预测最终复燃,ROC曲线下面积为0.86(95%CI 0.73-0.99)。
- 最终治疗无应答者未表现出相同的HRP2清除模式,即使缺乏其他疗效不佳指征。
核心结论
- 抗疟治疗成功后HRP2清除动力学一致,提示存在共同的生物学清除机制;最终治疗无应答者未表现出相同的清除模式,即使缺乏其他疗效不佳指征。
研究设计与样本
- 在安哥拉、坦桑尼亚和塞内加尔疗效试验中,对537例恶性疟患者纵向采集样本检测治疗后HRP2浓度,用一阶动力学清除模型估算半衰期,并评估治疗第3天HRP2浓度与感染复燃的关联。
主要发现
- 尽管基线HRP2浓度在受试者间差异很大,但浓度始终呈一阶指数下降。
- HRP2半衰期中位数在安哥拉为4.5天(IQR 3.3-6.6天),在坦桑尼亚为4.7天(IQR 4.0-5.9天),在塞内加尔为3.0天(IQR 2.1-4.5天)。
- 治疗第3天HRP2浓度可预测最终复燃,ROC曲线下面积为0.86(95%CI 0.73-0.99)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The response to antimalarial treatment is assessed using serial microscopy. New techniques for accurate measurement of the Plasmodium falciparum histidine-rich protein 2 (HRP2) antigen have allowed for monitoring of the antigen concentration over time, offering a potential alternative for assessing treatment response. METHODS: Posttreatment HRP2 concentrations were measured in samples obtained longitudinally from 537 individuals with P. falciparum malaria who were participating in efficacy trials in Angola, Tanzania, and Senegal. The HRP2 half-life was estimated using a first-order kinetics clearance model. The association between the HRP2 concentration 3 days after treatment and recrudescence of infection was assessed. RESULTS: Despite substantial variation in HRP2 concentrations among participants at baseline, concentrations consistently showed a first-order exponential decline. The median half-life of HRP2 was estimated to be 4.5 days (interquartile range [IQR], 3.3-6.6 days) in Angola, 4.7 days (IQR, 4.0-5.9 days) in Tanzania, and 3.0 days (IQR, 2.1-4.5 days) in Senegal. The day 3 HRP2 concentration was predictive of eventual recrudescence, with an area under the receiver operating characteristic curve of 0.86 (95% confidence interval, .73-.99). CONCLUSIONS: Consistent HRP2 clearance dynamics following successful antimalarial treatment imply a common underlying mechanism of biological clearance. Patients who ultimately did not respond to treatment did not exhibit this same pattern of clearance, even in the absence of other indications of inadequate response to treatment.
引用
- Plucinski MM, Dimbu PR, Fortes F, et al. Posttreatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum Malaria. J Infect Dis. 2018. PMID: 29220497. doi:10.1093/infdis/jix622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。